Discover
Stocks
Consumer Goods
VERV
VERV
Verve Therapeutics Inc
14.24
-0.97 (-6.38%)
Delayed Prices By NASDAQ,
in USD
Market Open
Invest
Buy
VERV
Verve Therapeutics Inc
Overview
Stats
Chart
Analysis
News
Invest
Buy
FINANCIAL SUMMARY
For the quarter ended 31/12/2022, Verve Therapeutics Inc's revenues increased by 8.93% and amounted to 1.01M. Net income increased by 9.08% to -41.09M. Net assets increased by 0.55% to 550.93M and EPS increased from -0.79 to -0.67.
VERV's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
-245.75%
Net Profit Margin
-2,027.14%
Operating Margin
-8,536.17%
Return On Investment
-64.54%
Buy
S
14.24